RE: RE: Encouraging Interims11 Jun 2018 09:34
That was the interim breast cancer update, 4 out of 20 patients had no disease progression after 24 weeks which is the trial end point, so a 20% efficacy rate, as the results say it’s encouraging but not particularly exciting imo anyway